Clinical outcome in patients with peripheral artery disease and renal artery stenosis

Angiology

Volumn 61, Issue 1, 2010, Pages 58-65

  Esteban, Carlos ^a   Perez, Paulina ^a   Fernández Llamazares, Jaume ^a   Suriñach, Josep Maria ^b   Camafort, Miquel ^c   Martorell, Albert ^a   Monreal, Manuel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Hospital Comarcal Mora d'Ebre   (Spain)

Author keywords

Hypertension; Outcome; Renal artery stenosis; Renal function

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOGRAPHY; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT;

HUMANS; HYPERTENSION; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RENAL ARTERY OBSTRUCTION;

EID: 73449101827     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708329336     Document Type: Article

References (29)

1. Missouris CG, Buckenham T., Cappuccio FP, MacGregor GA Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med. 1994 ; 96: 10-14.
2. Iglesias JI, Hamburger RJ, Feldman L., Kaufman JS The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease. Am J Med. 2000 ; 109: 642-647.
3. Leertouwer TC, Pattynama PMT, Van den Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int. 2001 ; 59: 1480-1483.
4. Pillay WR, Kan YM, Crinnion JN, Wolfe JHN, for the Joint Vascular Research Group, UK. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. Brit J Surg. 2002 ; 89: 737-740.
5. Mui KW, Sleeswijk M., van den Hout H., van Baal J., Navis G., Woittiez AJ Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol. 2006 ; 17: 2069-2074.
6. Androes MP, Langan EM, Kalbaugh CA, Blackhurst DW, Taylor SM, Youkey JR Is incidental renal arteriography justified in a population of patients with symptomatic peripheral arterial disease ? Vasc Endovasc Surg. 2007 ; 41: 106-110.
7. Garovic VD, Textor SC Renovascular hypertension and ischemic nephropathy. Circulation. 2005 ; 112: 1362-1374.
8. Levin A., Linas S., Luft FC, Chapman AB, Textor S., for the ASN HTN Advisory Group. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007 ; 27: 212-220.
9. Williamson W., Abou-Zamzam A. Jr, Moneta G., et al. Prophylactic repair of renal artery stenosis is not justified in patients who require infrarenal aortic reconstruction. J Vasc Surg. 1998 ; 28: 14-20.
10. Cockcroft DW, Gault MH Prediction of creatinine clearance from serum creatinine. Nephron. 1976 ; 16: 31-41.
11. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000 ; 31: S1 - S96.
12. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterisation. J Am Soc Nephrol. 1992 ; 2: 1608-1616.
13. Conlon PJ, Little MA, Pieper K., Mark DB Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001 ; 60: 1490-1497.
14. Rihal CS, Textor SC, Breen JF, et al. Incidental artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002 ; 77: 309-316.
15. Buller CE, Nogareda JG, Ramanathan K., et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol. 2004 ; 43: 1606-1613.
16. De Silva R., Nikitin NP, Bhandari S., Nicholson A., Clark AL, Cleland JGF. Atherosclerotic renovascular disease in chronic heart failure: should we intervene ? Eur Heart J. 2005 ; 26: 1596-1605.
17. Murphy TP, Soares G., Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries 1996-2000. Am J Roentgenol. 2004 ; 183: 561-568.
18. Plouin PF Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management: PRO. Am J Kidney Dis. 2003 ; 42: 851-857.
19. Mailloux LU Atherosclerotic ischemic renal vascular disease: do published outcomes justify the overzealous diagnostic approaches ? Semin Nephrol. 2003 ; 23: 278-282.
20. Arthurs Z., Starnes B., Cuadrado D., Sohn V., Cushner H., Andersen C. Renal artery stenting slows the rate of renal function decline. J Vasc Surg. 2007 ; 45: 726-731.
21. Textor SC ACE inhibitors in renovascular hypertension. Cardiovasc Drugs Ther. 1990 ; 4: 229-235.
22. Losito A., Gaburri M., Errico R., Parente B., Cao PG Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol. 1999 ; 52: 339-343.
23. Losito A., Errico R., Santirosi P., Lupattelli T., Scalera GB, Lupattelli L. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transpl. 2005 ; 20: 1604-1609.
24. Hackam DG, Spence JD, Garg AX, Textor SC Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension. 2007 ; 50: 998-1003.
25. Löpez-Jiménez L., Camafort M., Tiberio G., et al, and the FRENA Investigators. Secondary prevention of arterial disease in very elderly people: results from a prospective Registry (FRENA). Angiology. 2008 ; 59: 427-434.
26. Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ Renovascular disease and the risk of adverse coronary events in the elderly. A prospective, population-based study. Arch Intern Med. 2005 ; 165: 207-213.
27. Cheung CM, Patel A., Shaheen N., et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007 ; 107: 35-42.
28. Coppola G., Novo S. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch Med Res. 2007 ; 38: 479-488.
29. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007 ; 45: 645-654.